Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of TAK-981 and TAK-981 Combinations Following Intratumoral CIVO® Microdosing in Patients With Head and Neck Cancer

NCT04065555 is registered in ClinicalTrials.gov with Presage Biosciences as lead sponsor.

NCT NCT04065555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04065555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of TAK-981 and TAK-981 Combinations Following Intratumoral CIVO® Microdosing in Patients With Head and Neck Cancer
Lead sponsor
Presage Biosciences
Phase
Phase 1
Overall status
Completed
Start date
October 7, 2020
Completion date
July 20, 2022
Enrollment
12 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer